Phase 1 ā Early testing in a small group of people (usually 20ā80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
City of Hope Medical Center, Duarte, California Children's Hospital Los Angeles, Los Angeles, California C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan